论文信息 - Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial - 字舞流文

Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial

T. Wijeratne | G. Donnan | B. Campbell | S. Davis | V. Thijs | L. Churilov | M. Parsons | A. Bivard | B. Yan | Henry Ma | A. MacDonald | G. Sharma | N. Yassi | Henry Zhao | G. Cloud | V. Yogendrakumar | M. Stephenson | David Anderson | A. Balabanski | Damien Easton | S. Coote | P. Choi | E. Mackey | F. Ng | J. Ng | M. Valente | Angelos Sharobeam | Ângela dos Santos | F. Langenberg | L. Olenko | A. Warwick | Karen Smith | Dominic Italiano | D. Anderson | A. Sharobeam | Ângela dos Santos | D. Italiano | S. Davis | Francesca Langenberg | Angela Dos Santos

[1] J. Grotta,et al. Comparison of Mobile Stroke Unit With Usual Care for Acute Ischemic Stroke Management: A Systematic Review and Meta-analysis. , 2022, JAMA neurology.

[2] James J. McCarthy,et al. Prospective, Multicenter, Controlled Trial of Mobile Stroke Units. , 2021, The New England journal of medicine.

[3] B. Mackert,et al. Association Between Dispatch of Mobile Stroke Units and Functional Outcomes Among Patients With Acute Ischemic Stroke in Berlin. , 2021, JAMA.

[4] Y. Zhou,et al. Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke. , 2020, The New England journal of medicine.

[5] T. Wijeratne,et al. Melbourne Mobile Stroke Unit and Reperfusion Therapy , 2019, Stroke.

[6] M. Krause,et al. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke , 2018, The New England journal of medicine.

[7] M. Jayaraman,et al. Rethinking Thrombolysis in Cerebral Infarction 2b: Which Thrombolysis in Cerebral Infarction Scales Best Define Near Complete Recanalization in the Modern Thrombectomy Era? , 2017, Stroke.

[8] G. Donnan,et al. Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials , 2016, Circulation.

[9] A. Demchuk,et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials , 2016, The Lancet.

[10] G. Donnan,et al. Perfusion computed tomography to assist decision making for stroke thrombolysis , 2015, Brain : a journal of neurology.

[11] Geoffrey A. Donnan,et al. Stroke Thrombolysis: Save a Minute, Save a Day , 2014, Stroke.

[12] A. Bivard,et al. Review of Stroke Thrombolytics , 2013, Journal of stroke.

[13] G. Donnan,et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. , 2012, The New England journal of medicine.

[14] Cyrus R Mehta,et al. Adaptive increase in sample size when interim results are promising: A practical guide with examples , 2011, Statistics in medicine.

[15] M. Kaste,et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[16] Werner Hacke,et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study , 2007, The Lancet.

[17] M. Kaste,et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.